TY  - GEN
AU  - Zelniker,Thomas A
AU  - Wiviott,Stephen D
AU  - Raz,Itamar
AU  - Im,KyungAh
AU  - Goodrich,Erica L
AU  - Furtado,Remo H M
AU  - Bonaca,Marc P
AU  - Mosenzon,Ofri
AU  - Kato,Eri T
AU  - Cahn,Avivit
AU  - Bhatt,Deepak L
AU  - Leiter,Lawrence A
AU  - McGuire,Darren K
AU  - Wilding,John P H
AU  - Sabatine,Marc S
TI  - Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus
SN  - 1524-4539
PY  - 2020///0214
KW  - Aged
KW  - Atherosclerosis
KW  - prevention & control
KW  - Cardiovascular Diseases
KW  - Clinical Trials as Topic
KW  - Diabetes Mellitus, Type 2
KW  - complications
KW  - Diabetic Cardiomyopathies
KW  - etiology
KW  - Diabetic Nephropathies
KW  - Female
KW  - Glucagon-Like Peptide Receptors
KW  - agonists
KW  - Humans
KW  - Hypoglycemic Agents
KW  - pharmacology
KW  - Kidney Diseases
KW  - Male
KW  - Middle Aged
KW  - Proportional Hazards Models
KW  - Sodium-Glucose Transporter 2 Inhibitors
N1  - Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
UR  - https://doi.org/10.1161/CIRCULATIONAHA.118.038868
ER  -